Skip to main content

BridgeBio Pharma, Inc.

BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001743881

In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.

Politicians who traded BBIO

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
7
Filings
5
Politicians
1
Buys / sells
7 / 0
Estimated volume
$56.0K
Sum of range midpoints
Politicians who traded BBIO
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
77 / 0$56.0KMay 11, 2026Jun 8, 2026

Trades

Reported trades in BridgeBio Pharma, Inc., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
BBIOBridgeBio Pharma, Inc. - Common StockBuySelfMay 11, 2026Jun 8, 202628 days$1K-$15KFiling
BBIOBridgeBio Pharma, Inc. - Common StockBuySelfApr 29, 2026May 8, 20269 days$1K-$15KFiling
BBIOBridgeBio Pharma, Inc. - Common StockBuySelfMar 3, 2026Apr 7, 202635 days$1K-$15KFiling
BBIOBridgeBio Pharma, Inc. - Common StockBuySelfMar 19, 2026Apr 7, 202619 days$1K-$15KFiling
BBIOBridgeBio Pharma, Inc. - Common StockBuySelfMar 18, 2026Apr 7, 202620 days$1K-$15KFiling
BBIOBridgeBio Pharma, Inc. - Common StockBuySelfSep 22, 2025Oct 10, 202518 days$1K-$15KFiling
BBIOBridgeBio Pharma, Inc. - Common StockBuySelfAug 8, 2025Sep 12, 202535 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.